OUHSC Research News – Monday, February 6, 2023
Notices and Reminders
Proposal Submission Timeline Calculating Tool
The Office of Research Administration (ORA) is pleased to announce the addition of a new proposal submission timeline calculating tool to the Research Administration website, which principal investigators and grant administrators can use to ensure they are meeting required internal review deadlines for submitting proposals to our office.
To use this calculator, please select your proposal type (Single Project Proposal vs. Multi-Project Proposal) and enter the sponsor's submission deadline in the box to calculate the date your proposal will be due to ORA (finalized proposal documents including all required signatures). The tool also calculates the due date to ORA for an optional proposal budget review.
Please follow the link below to access the calculating tool.
https://research.ouhsc.edu/research-administration/grants/internal-deadlines
Important ORA Notice: All grant and contract proposals MUST be submitted to ORA (through SoonerTrack) for review, approval, and submission, regardless of the type of grant or contract, whether it is for research, public outreach initiatives, professional or public services, or whether it involves payment. This includes contracts with OU Health.
Please note that all certifications, contracts, agreements, and other award acceptance documents must be signed by an ORA Authorized Official. Faculty and staff are NOT authorized to sign grants or contracts on behalf of the University or on behalf of any University department or employee. Only the ORA’s Authorized Official may accept a grant award or negotiate and execute contract details on behalf of the University.
Reminder of Upcoming New NIH Data Management and Sharing Policy Requirements
The National Institute of Health (NIH) has implemented a new Policy for Data Management and Sharing (DMS Policy), which will take effect January 25, 2023. The policy requires ALL new and competing proposals/renewals that will generate scientific data to submit a detailed plan outlining how data will be stored, protected, and ultimately shared. Below you can find some guidance and resources for creating a DMS Plan.
- For applications being developed for due dates on or after January 25, 2023, a DMS Plan (recommended to be two pages or less in length) should be attached unless not required by the Funding Opportunity Announcement (FOA) or Forms H Guidelines. Please note that a Resource Sharing Plan should still be included for sharing model organisms.
- If data management and sharing costs are budgeted in a detailed budget, this should be described in the budget justification. Data management and sharing costs should be categorized under “Other Direct costs” on their own line.
- If it is a modular budget and data management and sharing costs are planned, the “Additional Narrative” attachment should be included.
- Do not include hypertext (e.g., hyperlinks and URLs) in the DMS Plan attachment.
- NIH Resources: Check out the latest DMS policy information, resources, format page, and FAQs at sharing.nih.gov.
- ORA Webinar: Understanding the New NIH Data Management and Sharing (DMS) Policy (October. 26, 2022). To access the training, please click here
The Cell Biology Histology Core Laboratory is located in the Department of Cell Biology in the Biomedical Sciences Building (BMSB 527). The core laboratory provides histology service (tissue processing, sectioning, H&E staining, etc.) and usage of some histology/imaging equipment to investigators on campus. The core facility has a trained/certified histology technician who works closely with investigators on their needs. The turnaround time is fast/short. Submission of a small number of specimens for paraffin embedding, sectioning, and H&E staining, are routinely ready for pick up the next day. Larger submissions naturally require more time, but are usually ready for pickup within 2-3 days. For more information please visit the website shown below.
https://basicsciences.ouhsc.edu/cb/Department-Facilities/Histology-Core
Workshops and Seminars
2023 Oklahoma Gero-Oncology Symposium
Date: Tuesday, April 4, 2023
Time: 8:15 - 5:25 PM CST | Reception to Follow
Location: In-person & via Zoom
Nicholson Tower, Floor 5, 1000 NE 13th St. Oklahoma City, OK 73104
Description: Learn about the developments and progress happening in geriatric oncology regarding sarcopenia in aging and cancer cachexia from leading experts across the country. This symposium will feature a roundtable discussion with speakers from NCI and NIA as well as a poster session.
Full agenda coming soon.
Sponsored by OU Health Stephenson Cancer Center and the Oklahoma Nathan Shock Center on Aging
Questions? If you have any questions regarding the symposium, please email Emily Hulseberg at emily-hulseberg@ouhsc.edu.
Registration: https://oklahomanathanshockcenteronaging.org/symposium-registration/
Abstract Submissions: https://oklahomanathanshockcenteronaging.org/abstract-submissions/
Transnetyx Tag Center Presentation
Date: Monday, February 13th
Time: 1:30 PM to 2:30 PM
Location: OUHSC - BRC 109
Introducing your NEW TAGCenter at OUHSC
Your automated genotyping experience is about to get even better. Join us for refreshments on Monday February 13th, as we introduce you to the Transnetyx TAGCenter Program. With the new and improved TAGCenter, you will be able to easily drop of samples, and get supplies. No other program offers automated genotyping like the Transnetyx TAGCenter Program. It’s the most convenient way to access fast, easy, and accurate genotyping in 72 hours or less— guaranteed. Soon, you’ll have even more time to focus on what matters most, your research that leads to discovery.
Questions? Contact: Christine Giammaruti cgiammaruti@transnetyx.com 832.849.8540; Please refer to the attached flyer.
2023 Annual Cancer Research Symposium
Registration and Abstract Submission Open Now!
The Annual Cancer Research Symposium is a one-day event with research focused in cancer biology, cancer prevention and control, and cancer therapeutics. The target audience is faculty, staff, postdoctoral and graduate students, and other cancer research focused colleagues.
WHEN Friday, March 10, 9:30 am - 5:10 pm (Reception to follow)
WHERE Nicholson Tower - 1000 NE 13th St. OKC, OK 73104
REGISTER Register HERE.
Questions? If you have any questions regarding the symposium, please contact Emily Hulseberg at Emily-Hulseberg@ouhsc.edu.
OCRID 10th Annual Research Symposium
Date: Tuesday, April 11, 2023, 8:00 AM – 6:00 PM CDT
Location: McKnight Center for the Performing Arts, 705 West University Avenue Stillwater, OK 74074
Description: The Oklahoma Center for Respiratory and Infectious Diseases is a multi-institutional center with investigators coming from Oklahoma State University, University of Oklahoma, and the Oklahoma Medical Research Foundation.
The OCRID Annual Research Symposium provides an opportunity for researchers and students in the fields of respiratory and infectious diseases to gather, network, and learn together from a group of outstanding local and national leaders in their fields. Research disciplines include molecular biology, pathology, animal models, disease pathogenesis, therapeutics, molecular mechanisms, and bioengineering.
The one-day symposium features keynote speakers, showcases the progress of OCRID investigators’ projects and the update from OCRID core facilities, and hosts a poster competition with cash prizes. A catered breakfast, refreshment breaks, and lunch will be provided throughout the day.
Registration and additional information: Please refer to the attached flyers.
OUHSC Funding Opportunities
OUHSC College of Medicine Research Fund
Description: Proposals are being accepted from full time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund. COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early stage investigators in the College of Medicine. The guidelines are included with this notice. Applications will be reviewed by a scientific panel whose composition will be determined on the types of applications received. Awards generally fall within the $20,000 to $45,000 range ($45,000 maximum request).
All applications must be routed through the Office of Research Administration and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official.
Below are New Guidelines for routing applications and for formatting applications for the COLLEGE OF MEDICINE ALUMNI ASSOCIATION (COMAA) research program:
- Submission of application for review
- At least five days prior to submission of the grant application, you must submit an electronic routing form using SOONERTRACKGRANTS (http://soonertrack.ouhsc.edu/SoonerTrackGrants.aspx).
- This program follows a Just-In-Time application process; therefore, approval of Institutional Review Board, Institutional Animal Care and Use Committee, Radiation Safety Committee and Institutional Biosafety Committee, where applicable, are not needed unless the application is being recommended for COMAA funding. Applicants should only submit this information when it is requested by the Office of the Vice President for Research. All protocols must be approved by the relevant review committees before funds are awarded.
- The completed COMAA application must be submitted via e-mail to COMAA-Research@ouhsc.edu (cc marybeth-humphrey@ouhsc.edu) no later than 5 pm, Wednesday, April 5, 2023. The application must be a single file in a pdf format and be titled “COMAA_[PI Name]”. Only applications that conform to the COMAA Grant Guidelines will be forwarded to the Grant Review Panel for consideration.
- Questions about the application submission process should be addressed to Associate Dean for Research for the College of Medicine, Dr. Mary Beth Humphrey (Marybeth-humphrey@ouhsc.edu).
Please submit an electronic copy of the application along with a copy of the Completed and Approved Soonertrack Routing Form (Soonertrackgrants.ouhsc.edu). A screenshot of the completed online PDF form will be accepted). Application must be reviewed and approved for submission by the Office of Research Administration (ORA) prior to the final application being submitted.
The start date for funded COMAA proposals will be July 1, 2023.
Applications Due: Applications should be sent electronically to COMAA-Research@ouhsc.edu by 5 pm on Wednesday, April 5, 2023.
Guidelines for the Submission of Proposals: Please refer to the attached application guide.
Call for Applications: PHF Equipment, Symposium, and Seed Grant Programs
Grant Type
|
Deadline
|
Research Support
|
February 24, 2023
|
New Investigator Seed (requires nomination by college)
|
March 10, 2023
|
Clinician Scientist Development
|
March 10, 2023
|
Team Science
|
March 24, 2023
|
Presbyterian Health Foundation (PHF) Research Support Grant Program – Request For Applications
- Cycle I PHF Research Support Grant Program Deadline: February 24, 2023
The PHF Research Support Grant Program will help support senior doctoral graduate students working on an externally funded research project in order to accelerate progress on the project, increase the number of publications on the project, and position the project for continued external funding. Outcomes of this program will be based upon work performed by the graduate student resulting in publications and external funding and will be carefully recorded and tracked.
The Principal Investigator must be an OUHSC primary faculty member. Principal Investigators who are full-time OUHSC faculty members, have external funds that support the project a senior graduate student is working on, and are the research mentor of the senior doctoral graduate student are eligible to apply.
Graduate students being supported by the PHF Research Support Grant program must be doctoral graduate students, have finished the majority of their coursework, and have a dissertation research project that is supporting an externally funded research project. The PHF funds must only fund that part of the stipend where the student is working on the externally funded research project. The Principal Investigator must have the funds to support the externally funded research project that the graduate student is working on and is expected to have funds to cover the rest of the graduate student’s stipend and other costs related to the graduate student’s education. Second year and third year funding is dependent upon meeting milestones proposed in prior year grant proposal. There are no restrictions on holding other PHF Grants during the duration of this award. A Principal Investigator may not hold more than two PHF Research Support Grants concurrently.
Presbyterian Health Foundation (PHF) New Investigator Seed Grant Program – Request For Applications
- Cycle I PHF New Investigator Seed Grant Program Deadline: March 10, 2023
The primary objective of the PHF New Investigator Seed Grant Program is to provide a two-year grant for OUHSC New Investigators to initiate research programs and obtain extramural funding. A secondary objective is to fund highly promising New Investigators from each of the six OUHSC professional colleges. Applicants must fit the following definition of a New Investigator: An investigator who has not previously received substantial, independent funding from NIH (e.g. R01-type funding) or a comparable funding agency. Multi-PI applications are not allowed. Each of the six OUHSC professional colleges (Allied Health, Dentistry, Medicine, Nursing, Pharmacy, and Public Health) may nominate one faculty member for this award. Applicants must be nominated by their professional college in order to apply for this award. The professional college nominating the faculty member must agree to assign a mentor for this project and must commit to providing the mentor with $2,500/year for mentoring activities; the mentor does not need to be an OUHSC faculty member. Each college may set up their own nomination process for this award.
The Principal Investigator must be an OUHSC primary faculty member. Principal Investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to ORA4PHF@ouhsc.edu
PHF New Investigator Seed Grant recipients may not hold a PHF Bridge Grant, a PHF Clinician Scientist Development Grant, a PHF Team Science Grant, a Research Support Grant, or a PHF Seed Grant for the duration of this award.
Presbyterian Health Foundation (PHF) Clinician Scientist Development Grant Program – Request For Applications
- Cycle I PHF Clinician Scientist Development Grant Program Deadline: March 10, 2023
The primary objective of the PHF Clinician Scientist Development Grant Program is to provide funding to a new or early stage clinician scientist faculty member. This award is designed to support the applicant’s clinical and/or translational research project and to assist him or her with advancing this research project to a level that will be competitive for funding through a federal career development award mechanism. This program can provide funding for up to two years. The second year of funding, will be based on successful achievement of identified milestones, completion of an application for Year Two funds, and whether funds are available.
The Principal Investigator must be an OUHSC primary faculty member with appointment at OUHSC as an Assistant Professor. New or early stage clinical scientist faculty members with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to ORA4PHF@ouhsc.edu). Applicants must not have had a prior NIH career development award or an independent NIH R01 award; must have an independent clinical and/or translational research project; must have an identified senior, experienced research mentor; and may not have another PHF grant during the duration of this award.
Presbyterian Health Foundation (PHF) Team Science Grant Program – Request For Applications
- Cycle I PHF Team Science Grant Program Deadline: March 24, 2023
The primary objective of this PHF Team Science Grant is to foster innovative, collaborative approaches to research projects involving multiple investigators. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two investigators and their respective expertise and/or disciplines. The proposal must consist of two or more investigators, with the majority at OUHSC, who can develop a broadly based, multidisciplinary research program focused on a specific disease entity, biomedical problem area, or clinically relevant problem. The combination and integration of studies may include basic, clinical, community-based and/or translational research endeavors. The proposal should focus on developing collaborative relationships and co-authored papers required for submission of multi-PI grants, program project grants, center grants, or other large collaborative-type grants (PCORI or AHRQ). The funding for this program can be for up to three years with the 2nd and 3rd year of funding, if funds are available, based on successful achievement of identified milestones, quality of specified milestones to be met during the next year of funding, and submission of a team-type grant application by the end of the 2nd year.
Each proposal submitted must consist of two or more investigators with a single investigator identified as the Contact PI/Team Leader. The Contact PI/Team Leader must be an OUHSC primary faculty member; adjunct faculty members are not eligible. At least half of the investigators on the team must be OUHSC primary faculty members. The other investigators may be from other institutions.
Guidelines and Application Forms are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).
- A biotech rare disease company is seeking novel research and technologies to address rare metabolic diseases, in particular amino acid metabolism and lysosomal storage disorders. Both novel therapeutics, combination therapies and platform technologies are of interest; platform technologies should be applicable to multiple diseases. Approaches of interest include gene editing, gene replacement therapies, and RNA modalities; CRISPR, base editing and prime editing are of high interest. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 02/15).
- A global mining company is looking for new applications for the mineral polyhalite in animal nutrition. Approaches of interest include granule-form polyhalite in animal feed, methods to achieve different forms or derivatives on polyhalite, and development and testing polyhalite formulations as animal feed or nutritional supplement. Out of scope are applications to fertilize crops, unless such approach improves nutritional value of the crop for animal nutrition. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 02/15).
- AstraZeneca is looking to develop innovative approaches to better understand the folding of short and long reads to reveal interactions that create unique, higher order folding structures. They are seeking partners who can help develop AI/physics-based methodologies for predicting RNA tertiary structure and folding accurately, in particular related to druggable binding sites. Submission entails a 1-pg non-confidential proposal form, including workplan and budgetary requirements. (deadline 03/01).
Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit Description: Grant proposals are being accepted for the 2023 Spring cycle from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $100,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Grant template and Submission Checklist provided with this notice. Investigators should request the budget template from the Protocol Support Unit.
Deadline: April 3, 2023 at 5 pm CST
Link to the full announcement or a flier: Please refer to the attached flyer for additional funding criteria and details
Canopy Health Funding Opportunity
Canopy Healthtech Program is a philanthropic, multi-institutional program that accelerates the translation of intellectual property at Oklahoma universities into commercially viable virtual health technologies. Canopy connects Oklahoma clinicians and technologists with each other and the local and national innovation ecosystem to support the development of virtual health technologies that satisfy current, pressing clinical pain points, ultimately resulting in new Oklahoma startups. Funds are available to cover multiple concept and seed-stage projects, including associated wrap-around business and operational resources (marketing, quality systems, regulatory, and reimbursement). They are especially interested in virtual technologies that address challenges in women’s, mental, and rural health. All projects and their budgets are evaluated on their own merit: there is no minimum or maximum funding limit (beyond the financial capacity of Canopy). Each investigator should determine the funds required to progress the project to the next stage of available funding and justify their request accordingly.
The attached Canopy RFP outlines the inaugural program of Canopy Healthtech rolling out in 2023: the Canopy FUND. The Canopy Fund will grant nondilutive seed and concept awards to Oklahoma universities, totaling approximately $400,000 of investment. Award amount is at the discretion and justification of each inventor and should be used to complement institution-specific resources. Applicants are expected to familiarize themselves with this RFP, participate in the application process, and adhere to the deadlines herein. Applicants are further expected to be reasonably available to the Canopy team and OTT to answer any questions that may arise in this process. Please see the attachment for further details and a complete description of the application process. Contact Rachel Lane-McClain (rlane@ou.edu) or Dr. Thomas Wavering (wavering@ou.edu) if you have further questions.
Canopy invites applications from principal investigators (PIs) who meet the following eligibility criteria:
- Teams should have two PIs, one with expertise in the technical domain, the other in the clinical setting.
- Both PIs must reside in Oklahoma full time
- Although Canopy is specifically focused on forging connections between academic and clinical partners, we are open to virtual health technologies proposed by any representative of a participating institution. If you have an idea for a virtual health technology and are employed or a student at OU, OSU, or TU, please reach out via our website.
- New applicants must attend at least five sessions of the Canopy PREP commercialization series.
NIH Notices
- Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2023 Councils
(NOT-OD-23-066)
- Clarification and Guidance for Applicants Preparing Applications for the Spring 2023 Due Dates During the COVID-19 Pandemic
(NOT-OD-23-067)
- Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2023
(NOT-OD-23-076)
- Notice of content visibility for tables located in Part 2. Full Text of Announcement in RFA-FD-23-027 "Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed"
(NOT-FD-23-006)
- Notice announcing Webinar and Frequently Asked Questions (FAQs) for PAR-23-037 NICHD Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities
(NOT-HD-23-002)
- Notice of NHGRI Participation in NOT-OD-23-044 "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
(NOT-HG-23-019)
- Notice of Information for RFA-OD-21-003, "Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)"
(NOT-OD-23-078)
- Notice of Information for RFA-OD-21-004, "Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)"
(NOT-OD-23-079)
- Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity, Equity, Inclusion, and Accessibility Across NIAID Extramural Activities
(NOT-AI-23-017)
- Request for Information on Existing Data Sharing Processes for NIH-Funded Research
(NOT-CA-23-023)
- Request for Information (RFI): Input for developing the 2024-2028 National Institute of Environmental Health Sciences Strategic Plan
(NOT-ES-23-005)
- Request for Information (RFI): Gaps and Opportunities in Global Mental Health Research
(NOT-MH-23-175)
- Notice of NIAAA's participation in NOT-OD-23-044 "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact"
(NOT-AA-23-007)
- Notice of the National Eye Institute participation in NOT-OD-23-044, "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
(NOT-EY-23-004)
- Notice of Clarification for the Research Scope in RFA-HD-24-002 "Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)"
(NOT-HD-23-004)
- Notice of Early Expiration of NOT-HL-21-017, "Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)"
(NOT-HL-23-074)
- Notice to expire NIHs Continuity Supplements (NOT-OD-20-054 and NOT-OD-20-055)
(NOT-OD-23-074)
- Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44)
(NOT-HL-23-066)
- Notice of Special Interest (NOSI) for Administrative Supplements: Harmonization and Joint Analysis of Human Brain Single-Cell Datasets
(NOT-NS-23-042)
- Notice of Special Interest (NOSI): Revision Applications to add a Curation and Informatics Component to existing Animal and Biological Material Resource Centers (P40) (Clinical Trials Not Allowed)
(NOT-OD-23-068)
NIH Funding Opportunities
- Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)
(PAR-22-262)
Application Receipt Date(s): January 07, 2024
- Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
(PAR-23-077)
Application Receipt Date(s): Multiple dates, see announcement.
- Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
(PAR-23-089)
Application Receipt Date(s): March 14, 2024
- Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required)
(PAR-23-107)
Application Receipt Date(s): March 17, 2023
- Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed)
(PAR-23-108)
Application Receipt Date(s): March 17, 2023
- NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
(PAR-23-111)
Application Receipt Date(s): May 07, 2026
- Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
(PAR-23-112)
Application Receipt Date(s): January 07, 2026
- Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed)
(RFA-AG-24-018)
Application Receipt Date(s): September 22, 2023
- Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)
(RFA-EB-23-001)
Application Receipt Date(s): October 02, 2023
- FDA OMHHE Health Equity Innovation Award: Racial & Ethnic Minority Acceleration Consortium for Health Equity (REACH) (U01) Clinical Trials Optional
(RFA-FD-23-010)
Application Receipt Date(s): April 06, 2023
- Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
(RFA-MD-23-002)
Application Receipt Date(s): September 06, 2023
- Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
(RFA-MD-23-003)
Application Receipt Date(s): September 06, 2023
Other Funding Opportunities
HRSA Nurse Anesthetist Traineeship (NAT) Program
Description: The purpose of the Nurse Anesthetist Traineeship (NAT) program is to increase the supply and distribution of Certified Registered Nurse Anesthetists (CRNAs) who are well prepared and well positioned to practice independently and collaboratively within interprofessional teams and to deliver evidence-based, high quality, and safe anesthesia and pain management services. The program aims to expand access to anesthesia services, especially to rural, urban, and tribal underserved communities nationwide. Eligible grant award recipients are accredited institutions that educate registered nurses to become nurse anesthetists; recipient institutions, in turn, disburse funds to students in the form of traineeship support.
Applications Due: February 10, 2023
Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-002
The International Center for Responsible Gaming - REQUEST FOR APPLICATIONS ON RESEARCH ON PRE-COMMITMENT AS A PREVENTION MEASURE TO REDUCE GAMBLING-RELATED HARMS
Description: The International Center for Responsible Gaming (ICRG) invites investigators to apply for a two-year Large Grant to study the effectiveness of “pre-commitment,” a prevention strategy that encourages gamblers to set limits on money and time spent gambling. Applicants may request up to a total of $75,000 per year for up to two years plus 15 percent in Facilities & Administration costs. Total amount that may be requested is $172,500.
Application Deadline: May 15, 2023
Link to Full Announcement: https://www.icrg.org/information/apply-for-icrg-funding
Cystic Fibrosis Foundation Clinical Fellowship Awards
Description: These awards encourage specialized training early in a physician's career and prepare candidates for careers in academic medicine. Fellowships are available for additional basic and/or clinical research training in the third, fourth, and fifth years to qualified applicants. These awards are up to $100,000 and include $80,000 for stipend and $20,000 for research costs (indirect costs are not allowed). Applicants for these awards must submit a proposal of the research studies to be undertaken and other specialized training that will be offered during the funding period.
Application deadlines:
First and Second Year Fellowships: March 1, 2023
Third, Fourth, and Fifth Year Fellowships: February 16, 2023
Link to Full Announcement: https://www.cff.org/researchers/clinical-fellowship-awards
Cystic Fibrosis Foundation LEAPP CF: Leadership and Education Advanced Practice Provider Fellowship Program
Description: CFF recognizes the growing demand to recruit and retain Advanced Practice Providers (APPs) trained to address the complex needs of a growing and aging cystic fibrosis (CF) population. APPs are highly effective practitioners who fulfill an array of roles in CF Centers including the provision of clinical care, leadership in QI, research, and newborn screening. LEAPP is a two-year program in comprehensive outpatient CF care offering an in-depth structured competency-based curriculum in CF and mentored clinical and professional experiences. For questions about the RFA please contact Cynthia George at cgeorge@cff.org.
Full application: March 7, 2023
Link to Full Announcement: https://www.cff.org/researchers/leapp-cf-leadership-and-education-advanced-practice-provider-fellowship-program
Cystic Fibrosis Foundation Multiple Principal Investigator Clinical Award
Description: The Multiple Principal Investigator (MPI) Clinical Award provides support for multi-investigator-initiated clinical research projects that have the potential to make an important contribution to the CF Foundation’s mission. Research projects may be designed to address a range of research areas, from clinical pilot and feasibility work to clinical (observational/interventional), translational or epidemiologic study approaches. Each investigator is expected to be a significant contributor to the project and share the responsibility and authority for leading and directing the project. Collaborations that bring new investigators and technologies into the CF research community will be given highest priority. Please note that applicants must speak with program staff prior to submission of an LOI. For questions, please contact Dara Riva (driva@cff.org).
Letter of Intent Due: March 22, 2023
Link to Full Announcement: https://www.cff.org/researchers/multiple-principal-investigator-clinical-award
Cystic Fibrosis Foundation Health Equity Team Science Award
Description: The Health Equity Team Science Award RFA will help address key research questions related to health disparities and to improve health equity within the CF Community. The RFA aims to fund cross-disciplinary teams that may propose up to three related research projects (each led by a separate principal investigator) that share a well-defined theme and overall objective. We are holding a webinar on February 28, 2023 from 1-2pm ET to review RFA content and the submission process, and will allow time for Q&A. Please note that applicants must speak with program staff prior to submission of an application. For questions, please contact Dara Riva (driva@cff.org).
Letter of Intent Due: March 29, 2023
Link to Full Announcement: https://www.cff.org/researchers/health-equity-team-science-award
NSF Division of Molecular and Cellular Biosciences Core Programs (MCB)
Description: This solicitation calls for proposals in research areas supported by the four MCB core clusters, including: (i) structure, dynamics, and function of biomolecules and supramolecular assemblies, especially under physiological conditions (Molecular Biophysics); (ii) organization, processing, expression, regulation, and evolution of genetic and epigenetic information (Genetic Mechanisms); (iii) cellular structure, properties, and function across broad spatiotemporal scales (Cellular Dynamics and Function); and (iv) systems and/or synthetic biology to study complex interactions through modeling or manipulation or design of living systems at the molecular-to-cellular scale (Systems and Synthetic Biology). All MCB clusters prioritize projects that integrate across scales, investigate molecular and cellular evolution, synergize experimental research with computational or mathematical modeling, and/or develop innovative, broadly applicable methods and technologies. Projects that bridge the intellectual edges between MCB clusters are welcome. Projects that integrate molecular and cellular biosciences with other subdisciplines of biology are also welcome through the new Integrative Research in Biology (IntBIO) track.
Full Proposal Deadline: Proposals Accepted Anytime
Link to Full Announcement: https://beta.nsf.gov/funding/opportunities/division-molecular-cellular-biosciences-core